Emcure Pharmaceuticals IPO GMP / Grey Market Premium, Kostak Rates & SS Today
Last Updated Date: Jul 07, 2024Emcure Pharmaceuticals is about to release its IPO on July 3, 2024. The issue is closing on July 5, 2024, and is currently having an active grey market. The Emcure Pharmaceuticals IPO GMP is running at a stable rate as per the current situation.
In IPO, the GMP or the Grey Market Premium is the premium amount at which the IPO shares are traded before getting listed in the stock market.
However, the QIB and the HNI numbers are the key indicators of GMP in the case of Emcure Pharmaceuticals IPO. The company intends to raise Rs 1,952.03 Cr. by the released issue.
Emcure Pharmaceuticals IPO GMP Rates, Kotak rates & SS
This particular table represents everything related to the IPO event from its opening and closing date along with the face value of the issue.
You can check this table related to know the IPO size, price band along with listing details, and more.
Date | GMP (in INR) | Kostak (in INR) | Subject to Sauda (in INR) |
July 2024 | |||
July 2024 | |||
July 2024 | |||
July 2024 | |||
July 2024 |
Check out Related IPO Links:
Review Emcure Pharmaceuticals IPO |
Emcure Pharmaceuticals IPO Allotment |
LIVE Subscription – Emcure Pharmaceuticals IPO |
Open Free Demat Account Now!
Emcure Pharmaceuticals IPO Date / Timetable
Here, you will find the important dates and events of this IPO. Check the allotment status, visit us again once the subscription date is over.
Face Value | Rs 10 |
Price Band | Rs 960 to Rs 1008 |
Listing At | BSE, NSE |
Min. Order Quantity | 14 Shares |
Listing Date | July 10, 2024 |
Offer for Sale | Rs 1,152.03 Cr. |
Fresh Issue | Rs 800.00 Cr. |
IPO Size | Rs 1,952.03 Cr. |
Tick Size | 1 |
Emcure Pharmaceuticals IPO – Financial Performance
The below-given table will give you an overall idea of the company’s financial performance. Check their net profit and loss statement about Emcure Pharmaceuticals IPO.
Amount (in INR & Million) | |||
31-Mar-24 | 31-Mar-23 | Mar-22 | |
Total Assets |
78,061.63
|
66,725.31
|
60,634.69
|
*Total Revenue |
67,152.41
|
60,317.16
|
59,188.60
|
Total Expense |
59,780.82
|
52,783.55
|
49,463.12
|
Profit After Tax |
5,275.75
|
5,618.45
|
7,025.56
|
Earnings per Equity Share (in Million)
31-Mar-24 | 31-Mar-23 | Mar-22 | |
Basic & Diluted |
27.54
|
29.42
|
36.62
|
FAQs Related to Emcure Pharmaceuticals IPO GMP
Check out FAQs on Emcure Pharmaceuticals IPO Grey Market Premium here –
What is the current Emcure Pharmaceuticals IPO GMP Price?
As on today, the Emcure Pharmaceuticals IPO GMP is Rs.NA.
What is the current Emcure Pharmaceuticals IPO Kostak Rate?
The Kostak rate is Rs NA for Emcure Pharmaceuticals IPO.
What is today’s Emcure Pharmaceuticals IPO Subject to Sauda Rate?
As on today, the Emcure Pharmaceuticals IPO Subject to Sauda is Rs NA.
Where to Check Emcure Pharmaceuticals IPO Allotment & Listing?
However, if you don’t want to miss out on the issue’s allotment status and the listing, you can refer to this LINK given here: IPO Allotment Status
What is Kostak Price?
To apply for an IPO, there is an application price or application charges that come along and is known as Kostak price. It is actually the premium amount at which IPO applications are being traded in the grey market.
Is GREY market buy or sell shares illegal?
Grey Market is basically trading that takes place before the stock of a company gets enlisted on the stock exchange.
It takes place before the IPO release and the prices may change at any time. Hence, it is unofficial trading and hence, not “illegal”.
Disclaimer:
The Emcure Pharmaceuticals IPO GMP which is mentioned in the table here is only valid for a specific date as mentioned in the header section. The Kostak is the premium that one gets by selling her/his IPO application to someone else before listing the issue. They can sell it in an off-market transaction. However, we aren’t buying/selling IPO forms on the IPO Grey market.
It is also requested that please do not subscribe for an IPO by just seeing the premium price. The reason being, the premium price varies and can change anytime before listing. Please subscribe only after considering the fundamentals of the companies.